← All organizations
Austin Health
Academic/HospitalWebsite ↗
Also known as: Austin Health | Austin Health Cancer Care | Austin Health, Melbourne | Austin Health, Melbourne, Australia | Department of Anaesthesia, Austin Health | Dept of Anaesthesia, Austin Health | Dr. Eliza Hawkes | Ludwig Institute for Cancer Research & Austin Health | Ludwig Oncology Unit, Austin Health | ONJCRI and Austin Health
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2002Last known activity
Feb 28, 2026
Timeline
1880s
- Jan 1, 1882
Austin Health— Founded
Drugs by trial phase (54 distinct, 49 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (12 own, 0 via acquisition)
Phase 2 (26 own, 0 via acquisition)
Phase 1 (10 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
- Acute Kidney Injury
- Alzheimer Disease
- Blood Coagulation Disorders
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Cholangiocarcinoma
- Colitis
- Colitis, Ulcerative
- Colorectal Neoplasms
- Coronary Artery Disease
- Delirium
- Depression
- Depression, Postpartum
- Depressive Disorder
- Diabetes Mellitus, Type 2
- Gastrointestinal Neoplasms
- Genital Neoplasms, Female
- Glioblastoma
- Heart Valve Diseases
- Hemostatic Disorders
- Hypogonadism
- Ischemia
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Follicular
- Lymphoma, Large B-Cell, Diffuse
- Melanoma
- Myocardial Ischemia
- Neuroendocrine Tumors
- Oliguria
- Ovarian Neoplasms
- Prostatic Neoplasms
- Psychomotor Agitation
- Renal Insufficiency
- Sciatica
- Sepsis
- Shock, Septic
- Small Cell Lung Carcinoma
- Syndrome
- Systemic Inflammatory Response Syndrome
- Ulcer
- Urinary Bladder Neoplasms
Recent trials (50)
- NCT07225465CollaboratorPhase 2Feb 28, 2026
- NCT06929663OfficialPhase 1Jul 2, 2025
- NCT05788081OfficialPhase 2Aug 31, 2023
- NCT05788081CollaboratorPhase 2Aug 31, 2023
- NCT05788081Overall official - principal investigatorPhase 2Aug 31, 2023
- NCT05523947OfficialPhase 1/Phase 2Aug 26, 2022
- NCT05182931Study chairPhase 2Jul 14, 2022
- NCT05182931CollaboratorPhase 2Jul 14, 2022
- NCT05796089Overall official - principal investigatorPhase 2Jan 1, 2022
- NCT05796089OfficialPhase 2Jan 1, 2022
- NCT04962126CollaboratorPhase 2Aug 17, 2021
- NCT04962126Overall official - principal investigatorPhase 2Aug 17, 2021
- NCT04969887OfficialPhase 2Aug 3, 2021
- NCT04969887Study chairPhase 2Aug 3, 2021
- NCT04454229Lead sponsorN/AJun 1, 2021
Details
- Founded
- Heidelberg, AU Jan 1, 1882
- Last known activity
- Feb 28, 2026